William Blair Downgrades Haemonetics (HAE) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- S&P 500, Nasdaq futures decline as US-Iran escalation rattles sentiment
- Oil gains over 2% as fresh military strikes threaten Hormuz shipments
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
JMP Securities Downgrades Haemonetics (HAE) to Market Perform
March 24, 2014 2:56 PM EDTJMP Securities downgraded Haemonetics (NYSE: HAE) from Market Outperform to Market Perform and removed its price target (priro $45.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $37.19 yesterday.... More
